Remove Digital Health Remove Drug Development Remove healthcare technology Remove Interoperability
article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

HealthTech M&A Soft Landing Areas: Digital therapeutics: Growing demand for personalised, data-driven treatments creates opportunities for companies with proven solutions. Interoperability and data analytics: Merging companies with expertise in connecting disparate healthcare systems and generating actionable insights can be valuable.

article thumbnail

Self-sovereign identity (SSI) - the future of Health Data?

Lloyd Price

Benefits for healthcare stakeholders: Streamlined patient onboarding: Verifiable credentials from SSI wallets can expedite patient registration and verification, reducing administrative burdens and improving wait times. This promotes data portability and user control across the healthcare landscape. Subscribe Today!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

Overall, the pain management market is poised for significant growth, fuelled by technological innovation and a growing demand for effective, non-opioid solutions. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

article thumbnail

European Parliament approves creation of the European Health Data Space: unified system for managing electronic health data across member states

Lloyd Price

Boost research and innovation: Researchers will have a secure platform to access and analyse large datasets for medical research, leading to advancements in disease prevention, treatment, and drug development. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis.